30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Teva Pharmaceutical Industries Ltd (TEVA)

Track

Over the last 90 days, Teva Pharmaceutical Industries Ltd. has seen 22 insider transactions, with a total sell value of over $42 million. Notably, key executives like the CFO and President & CEO have engaged in multiple proposed and planned sales, indicating significant divestment activity among top leadership.
Stock chart
Ticker: TEVA Exchange: TLV
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Shields Matthew
EVP, Global Operations
3 sales — total 300,000 USD
Sale 18 Jun 2026
Value US$263,384.93 | Price 224.28 | Shares 1,311
Sale 18 Jun 2026
Value US$3,918,069.98 | Price 183.88 | Shares 43,212
Proposed sale 18 Jun 2026
Value US$100,000.00 | Price 32.19 | Shares 1,000
Planned sale 11 Jun 2026
Value US$4,385,929.97 | Price 479.21 | Shares 2,565
Proposed sale 11 Jun 2026
Value US$186,512.04 | Price 176.54 | Shares 38,382
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 34.10 | Shares 1,000
Planned sale 5 Jun 2026
Value US$100,000.00 | Price 34.35 | Shares 1,000
Proposed sale 5 Jun 2026
Value US$100,000.00 | Price 34.35 | Shares 1,000
Planned sale 3 Jun 2026
Value US$100,000.00 | Price 32.87 | Shares 1,000
Proposed sale 3 Jun 2026
Value US$100,000.00 | Price 32.87 | Shares 1,000
Planned sale 14 May 2026
Value US$1,277,899.79 | Price 35.58 | Shares 35,912
Planned sale 14 May 2026
Value US$1,277,899.79 | Price 35.58 | Shares 35,912
Planned sale 14 May 2026
Value US$204,466.81 | Price 35.58 | Shares 5,746
Planned sale 14 May 2026
Value US$204,466.81 | Price 35.58 | Shares 5,746
Proposed sale 14 May 2026
Value US$1,482,366.60 | Price 35.58 | Shares 41,658
Planned sale 14 May 2026
Value US$5,457,375.39 | Price 35.61 | Shares 153,251
Proposed sale 14 May 2026
Value US$5,457,368.64 | Price 35.61 | Shares 153,251
Sale 6 May 2026
Value US$384,444.00 | Price 36.00 | Shares 10,679
Sale 5 May 2026
Value US$1,062,000.00 | Price 35.40 | Shares 30,000
Proposed sale 5 May 2026
Value US$1,062,000.00 | Price 35.40 | Shares 30,000
Sale 1 May 2026
Value US$5,045,117.72 | Price 34.99 | Shares 144,180
Proposed sale 1 May 2026
Value US$5,045,122.63 | Price 34.99 | Shares 144,180
Sale 30 Apr 2026
Value US$750,619.98 | Price 35.31 | Shares 21,258
Proposed sale 30 Apr 2026
Value US$750,633.14 | Price 35.31 | Shares 21,258
Sale 17 Mar 2026
Value US$1,871,816.38 | Price 30.14 | Shares 62,102
Proposed sale 17 Mar 2026
Value US$1,871,815.26 | Price 30.14 | Shares 62,102
Planned sale 5 Mar 2026
Value US$634,159.71 | Price 31.67 | Shares 20,025
Proposed sale 5 Mar 2026
Value US$634,159.70 | Price 31.67 | Shares 20,025
Planned sale 5 Mar 2026
Value US$250,940.40 | Price 31.67 | Shares 7,924
Proposed sale 5 Mar 2026
Value US$250,940.40 | Price 31.67 | Shares 7,924
Planned sale 5 Mar 2026
Value US$301,894.86 | Price 31.67 | Shares 9,533
Proposed sale 5 Mar 2026
Value US$301,894.86 | Price 31.67 | Shares 9,533
Planned sale 5 Mar 2026
Value US$547,704.98 | Price 31.67 | Shares 17,295
Proposed sale 5 Mar 2026
Value US$547,704.98 | Price 31.67 | Shares 17,295
Planned sale 5 Mar 2026
Value US$448,107.86 | Price 31.67 | Shares 14,150
Proposed sale 5 Mar 2026
Value US$448,107.86 | Price 31.67 | Shares 14,150
Sale 5 Mar 2026
Value US$35,690.29 | Price 31.67 | Shares 1,127
Proposed sale 5 Mar 2026
Value US$35,690.24 | Price 31.67 | Shares 1,127
Planned sale 5 Mar 2026
Value US$547,704.98 | Price 31.67 | Shares 17,295
Proposed sale 5 Mar 2026
Value US$547,704.98 | Price 31.67 | Shares 17,295
Planned sale 4 Mar 2026
Value US$1,231,310.23 | Price 32.95 | Shares 37,372
Planned sale 4 Mar 2026
Value US$664,256.13 | Price 32.46 | Shares 20,461
Planned sale 4 Mar 2026
Value US$1,087,950.32 | Price 32.46 | Shares 33,512
Proposed sale 4 Mar 2026
Value US$2,983,515.95 | Price 32.66 | Shares 91,345
Planned sale 4 Mar 2026
Value US$759,442.05 | Price 32.46 | Shares 23,393
Proposed sale 4 Mar 2026
Value US$759,442.05 | Price 32.46 | Shares 23,393
Planned sale 4 Mar 2026
Value US$366,102.17 | Price 32.46 | Shares 11,277
Proposed sale 4 Mar 2026
Value US$366,102.17 | Price 32.46 | Shares 11,277
Planned sale 4 Mar 2026
Value US$295,362.02 | Price 32.46 | Shares 9,098
Proposed sale 4 Mar 2026
Value US$321,658.26 | Price 32.46 | Shares 9,908
Sale 4 Mar 2026
Value US$38,502.90 | Price 32.46 | Shares 1,186
Sale 4 Mar 2026
Value US$48,339.64 | Price 32.46 | Shares 1,489
Planned sale 3 Mar 2026
Value US$2,159,537.93 | Price 32.36 | Shares 66,735
Planned sale 3 Mar 2026
Value US$2,014,403.78 | Price 32.36 | Shares 62,250
Proposed sale 3 Mar 2026
Value US$4,173,941.70 | Price 32.36 | Shares 128,985
Sale 3 Mar 2026
Value US$41,226.51 | Price 32.36 | Shares 1,274
Proposed sale 3 Mar 2026
Value US$41,226.51 | Price 32.36 | Shares 1,274
Planned sale 3 Mar 2026
Value US$13,333,314.32 | Price 32.36 | Shares 412,032
Planned sale 3 Mar 2026
Value US$1,000,017.99 | Price 32.36 | Shares 30,903
Proposed sale 3 Mar 2026
Value US$14,333,332.31 | Price 32.36 | Shares 442,935
Planned sale 3 Mar 2026
Value US$2,222,639.73 | Price 32.36 | Shares 68,685
Planned sale 3 Mar 2026
Value US$390,810.51 | Price 32.36 | Shares 12,077
Proposed sale 3 Mar 2026
Value US$2,613,450.24 | Price 32.36 | Shares 80,762
Planned sale 26 Feb 2026
Value US$11,634,708.29 | Price 33.64 | Shares 345,810
Proposed sale 26 Feb 2026
Value US$11,634,702.06 | Price 33.64 | Shares 345,810
Proposed sale 17 Feb 2026
Value US$15,324,798.00 | Price 34.22 | Shares 447,778
Proposed sale 17 Feb 2026
Value US$447,778.00 | Price 1.00 | Shares 447,778
Planned sale 15 Feb 2026
Value US$9,792,267.94 | Price 34.22 | Shares 286,122
Planned sale 15 Feb 2026
Value US$5,532,531.11 | Price 34.22 | Shares 161,656
Sale 16 Dec 2025
Value US$371,504.28 | Price 30.20 | Shares 12,300
Sale 16 Dec 2025
Value US$2,340,645.66 | Price 30.24 | Shares 77,400
Proposed sale 12 Dec 2025
Value US$4,527,000.00 | Price 30.18 | Shares 150,000
Sale 9 Dec 2025
Value US$3,311,125.73 | Price 28.68 | Shares 115,468
Sale 9 Dec 2025
Value US$2,817,676.84 | Price 28.70 | Shares 98,168
Sale 9 Dec 2025
Value US$3,413,077.55 | Price 28.75 | Shares 118,724
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
1,311 +41.7%
224.28
US$263,385 		1,311 +41.7% 224.28 US$263,385
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
43,212 +47.6%
183.88
US$3,918,070 		43,212 +47.6% 183.88 US$3,918,070
2026-06-18 2026-06-18 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
83,865
347.68
US$4,878,473 		83,865 347.68 US$4,878,473
2026-06-16 2026-06-11 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
1,000 -61.9%
34.10
US$100,000 		1,000 -61.9% 34.10 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
1,000
34.10
US$100,000 		1,000 34.10 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
1,000
34.10
US$100,000 		1,000 34.10 US$100,000
2026-06-08 2026-06-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
1,000 -0.5%
34.35
US$100,000 		1,000 -0.5% 34.35 US$100,000
2026-06-05 2026-06-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
1,000
34.35
US$100,000 		1,000 34.35 US$100,000
2026-06-04 2026-06-03 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
1,000 -61.9%
32.87
US$100,000 		1,000 -61.9% 32.87 US$100,000
2026-06-03 2026-06-03 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
1,000
32.87
US$100,000 		1,000 32.87 US$100,000
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
153,251 -47.1%
35.61
US$5,457,375 		153,251 -47.1% 35.61 US$5,457,375
2026-05-14 2026-05-14 PrS Proposed sale
Lippman Evan

Officer; EXECUTIVE VP BUSINESS DEVELOPMENT

Officer
41,658
35.58
US$1,482,367 		41,658 35.58 US$1,482,367
2026-05-14 2026-05-14 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
153,251
35.61
US$5,457,369 		153,251 35.61 US$5,457,369
2026-05-07 2026-05-06 S Sale
Weiss Amir

Chief Accounting Officer

Officer
10,679 -34.8%
36.00
US$384,444 		10,679 -34.8% 36.00 US$384,444
2026-05-07 2026-05-05 S Sale
Daniell Richard

EVP, Europe Commercial

Officer
30,000 -35.0%
35.40
US$1,062,000 		30,000 -35.0% 35.40 US$1,062,000
2026-05-05 2026-05-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
30,000
35.40
US$1,062,000 		30,000 35.40 US$1,062,000
2026-05-04 2026-05-01 S Sale
Sabag Mark

See "Remarks"

Officer
144,180 -64.1%
34.99
US$5,045,118 		144,180 -64.1% 34.99 US$5,045,118
2026-05-04 2026-05-01 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
144,180
34.99
US$5,045,123 		144,180 34.99 US$5,045,123
2026-05-04 2026-04-30 S Sale
Fox Christine

EVP, U.S. Commercial

Officer
21,258 -25.0%
35.31
US$750,620 		21,258 -25.0% 35.31 US$750,620
2026-04-30 2026-04-30 PrS Proposed sale
Christine Fox

Officer

Officer
21,258
35.31
US$750,633 		21,258 35.31 US$750,633
2026-03-19 2026-03-17 S Sale
Sabag Mark

See "Remarks"

Officer
62,102 -21.6%
30.14
US$1,871,816 		62,102 -21.6% 30.14 US$1,871,816
2026-03-17 2026-03-17 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
62,102
30.14
US$1,871,815 		62,102 30.14 US$1,871,815
2026-03-09 2026-03-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
20,025 -1.7%
31.67
US$634,160 		20,025 -1.7% 31.67 US$634,160
2026-03-09 2026-03-05 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
7,924 -8.5%
31.67
US$250,940 		7,924 -8.5% 31.67 US$250,940
2026-03-09 2026-03-05 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
9,533 -8.1%
31.67
US$301,895 		9,533 -8.1% 31.67 US$301,895
2026-03-09 2026-03-05 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
17,295 -16.8%
31.67
US$547,705 		17,295 -16.8% 31.67 US$547,705
2026-03-09 2026-03-05 PlS Planned sale
Jover Placid

See "Remarks"

Officer
14,150 -67.6%
31.67
US$448,108 		14,150 -67.6% 31.67 US$448,108
2026-03-09 2026-03-05 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,127 -9.4%
31.67
US$35,690 		1,127 -9.4% 31.67 US$35,690
2026-03-09 2026-03-05 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
17,295 -63.4%
31.67
US$547,705 		17,295 -63.4% 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Jover Placid

Officer; EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER

Officer
14,150
31.67
US$448,108 		14,150 31.67 US$448,108
2026-03-05 2026-03-05 PrS Proposed sale
Savage Brian

Officer; INTERIM CHIEF LEGAL OFFICER

Officer
1,127
31.67
US$35,690 		1,127 31.67 US$35,690
2026-03-05 2026-03-05 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
7,924
31.67
US$250,940 		7,924 31.67 US$250,940
2026-03-05 2026-03-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
20,025
31.67
US$634,160 		20,025 31.67 US$634,160
2026-03-05 2026-03-05 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
9,533
31.67
US$301,895 		9,533 31.67 US$301,895
2026-03-05 2026-03-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
37,372 -30.4%
32.95
US$1,231,310 		37,372 -30.4% 32.95 US$1,231,310
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
20,461 -14.2%
32.46
US$664,256 		20,461 -14.2% 32.46 US$664,256
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
33,512 -21.4%
32.46
US$1,087,950 		33,512 -21.4% 32.46 US$1,087,950
2026-03-06 2026-03-04 PlS Planned sale
Francis Richard D

President and CEO

Officer
23,393 -2.0%
32.46
US$759,442 		23,393 -2.0% 32.46 US$759,442
2026-03-06 2026-03-04 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
11,277 -10.4%
32.46
US$366,102 		11,277 -10.4% 32.46 US$366,102
2026-03-06 2026-03-04 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
9,098 -10.8%
32.46
US$295,362 		9,098 -10.8% 32.46 US$295,362
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,186 -12.3%
32.46
US$38,503 		1,186 -12.3% 32.46 US$38,503
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,489 -19.4%
32.46
US$48,340 		1,489 -19.4% 32.46 US$48,340
2026-03-04 2026-03-04 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
9,908
32.46
US$321,658 		9,908 32.46 US$321,658
2026-03-04 2026-03-04 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
23,393
32.46
US$759,442 		23,393 32.46 US$759,442
2026-03-04 2026-03-04 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
11,277
32.46
US$366,102 		11,277 32.46 US$366,102
2026-03-04 2026-03-04 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
91,345
32.66
US$2,983,516 		91,345 32.66 US$2,983,516
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
66,735 -35.1%
32.36
US$2,159,538 		66,735 -35.1% 32.36 US$2,159,538
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
62,250 -56.3%
32.36
US$2,014,404 		62,250 -56.3% 32.36 US$2,014,404
2026-03-05 2026-03-03 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,274 -30.3%
32.36
US$41,227 		1,274 -30.3% 32.36 US$41,227
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
412,032 -26.9%
32.36
US$13,333,314 		412,032 -26.9% 32.36 US$13,333,314
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
30,903 -4.6%
32.36
US$1,000,018 		30,903 -4.6% 32.36 US$1,000,018
2026-03-05 2026-03-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
68,685 -44.5%
32.36
US$2,222,640 		68,685 -44.5% 32.36 US$2,222,640
2026-03-05 2026-03-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
12,077 -48.5%
32.36
US$390,811 		12,077 -48.5% 32.36 US$390,811
2026-03-03 2026-03-03 PrS Proposed sale
Savage Brian

Officer; EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER

Officer
1,274
32.36
US$41,227 		1,274 32.36 US$41,227
2026-03-03 2026-03-03 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
442,935
32.36
US$14,333,332 		442,935 32.36 US$14,333,332
2026-03-03 2026-03-03 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
80,762
32.36
US$2,613,450 		80,762 32.36 US$2,613,450
2026-03-03 2026-03-03 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
128,985
32.36
US$4,173,942 		128,985 32.36 US$4,173,942
2026-03-02 2026-02-26 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
345,810 -85.7%
33.64
US$11,634,708 		345,810 -85.7% 33.64 US$11,634,708
2026-02-26 2026-02-26 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
345,810
33.64
US$11,634,702 		345,810 33.64 US$11,634,702
2026-02-18 2026-02-17 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
447,778
34.22
US$15,324,798 		447,778 34.22 US$15,324,798
2026-02-18 2026-02-17 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
447,778
1.00
US$447,778 		447,778 1.00 US$447,778
2026-02-18 2026-02-15 PlS Planned sale
Francis Richard D

President and CEO

Officer
286,122 -32.1%
34.22
US$9,792,268 		286,122 -32.1% 34.22 US$9,792,268
2026-02-18 2026-02-15 PlS Planned sale
Francis Richard D

President and CEO

Officer
161,656 -37.3%
34.22
US$5,532,531 		161,656 -37.3% 34.22 US$5,532,531
2025-12-18 2025-12-16 S Sale
Weiss Amir

Chief Accounting Officer

Officer
12,300 -68.5%
30.20
US$371,504 		12,300 -68.5% 30.20 US$371,504
2025-12-18 2025-12-16 S Sale
MIGNONE ROBERTO
Non-Executive Director
77,400 -17.4%
30.24
US$2,340,646 		77,400 -17.4% 30.24 US$2,340,646
2025-12-12 2025-12-12 PrS Proposed sale
Bridger Management, LLC (1)

Shareholder
150,000
30.18
US$4,527,000 		150,000 30.18 US$4,527,000
2025-12-11 2025-12-09 S Sale
Daniell Richard

Exec. VP, European Commercial

Officer
115,468 -70.5%
28.68
US$3,311,126 		115,468 -70.5% 28.68 US$3,311,126
2025-12-11 2025-12-09 S Sale
Sabag Mark

See "Remarks"

Officer
98,168 -65.0%
28.70
US$2,817,677 		98,168 -65.0% 28.70 US$2,817,677
2025-12-11 2025-12-09 S Sale
Sabag Mark

See "Remarks"

Officer
118,724 -44.0%
28.75
US$3,413,078 		118,724 -44.0% 28.75 US$3,413,078
Explore more

More insider trading research around Teva Pharmaceutical Industries Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America